Cytokinetics CYTK 深 沪
等待开盘 10-14 09:30:00 美东时间
61.62
-1.170
-1.86%
华盛通- 最 高63.05
- 今 开62.32
- 成交量 193.60万股
- 最 低 61.50
- 昨 收 62.79
- 总市值 85.67亿
- 52周最高 88.31
- 市盈率 静 --
- 换手率 1.39%
- 52周最低 57.83
- 委 比 76.23%
- 总股本 1.39亿
- 历史最高 110.25
- 量 比 0.91
- 振 幅 2.47%
- 历史最低 0.57
- 每 手 1
- 风险率 7.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
RBC Capital Maintains Outperform on Cytokinetics, Raises Price Target to $113
RBC Capital analyst Leonid Timashev maintains Cytokinetics (NASDAQ:CYTK) with a Outperform and raises the price target from $112 to $113.
10-08 22:45
Bumble, PIMCO Dynamic, Cytokinetics, Medifast, Grace
Insiders have been trading these 5 stocks: (($BMBL)), (($PDI)), (($CYTK)), (($M...
10-03 21:01
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
Cytokinetics, Inc. announced four presentations at the HFSA 2026 Annual Meeting in Phoenix, AZ, including two Late-Breaking Clinical Research and two oral presentations. The presentations focus on aficamten's efficacy, exercise performance improvements, right ventricular function, and dosing safety in hypertrophic cardiomyopathy (HCM). Aficamten, approved for obstructive HCM, is also being evaluated for non-obstructive HCM. The company plans to s...
10-02 11:30
Analysts Are Bullish on These Healthcare Stocks: Cytokinetics (CYTK), Oxford BioMedica (OXBDF)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
09-29 17:20
Aspen Aerogels, Sezzle, PIMCO, Kimbell, Cytokinetics Insider Moves
Insiders have been trading these 5 stocks: (($ASPN)), (($SEZL)), (($PDI)), (($K...
09-26 21:01
Here’s How Much You Would Have Made Owning Cytokinetics Stock In The Last 15 Years
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 15 years by 2.64% on an annualized basis producing an average annual return of 15.99%. Currently, Cytokinetics has a market capitalization of $9.70 billion. Buying $1000 In CYTK: If an investor had bought $1000 of CYTK stock 15 yea...
09-21 23:45
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Cytokinetics granted stock options for 52,834 shares and 35,025 RSUs to 23 employees hired in August and September 2026. The RSUs vest over 3 years, with 40% after the first year, 40% after the second, and 20% after the third. Stock options have an exercise price of $69.31, vesting over 4 years with monthly installments after the first year. The company focuses on cardiovascular treatments, including MYQORZO® (aficamten) for hypertrophic cardiomy...
09-17 20:00
If You Invested $1000 In Cytokinetics Stock 10 Years Ago, You Would Have This Much Today
Cytokinetics (NASDAQ:CYTK) has outperformed the market over the past 10 years by 10.3% on an annualized basis producing an average annual return of 23.89%. Currently, Cytokinetics has a market capitalization of $10.16 billion. Buying $1000 In CYTK: If an investor had bought $1000 of CYTK stock 10 ye...
09-11 23:45
Small-cap bears were back. Was IWM the warning sign?
The put-call ratio for the iShares Russell 2000 ETF (IWM) surged to 3.58, with Barchart saying the reading marked the highest level since April 2024. The ratio had climbed sharply in the latest readin...
09-02 23:29
